X-Energy, Inc. Class A Common Stock

X-Energy, Inc. Class A Common Stock Earnings Recaps

XE Industrials 2 recaps
Next earnings: March 3, 2027 (estimated) · full calendar
Q3 2026 Nov 14, 2026

X-Energy’s shares rose 2.9% after earnings, a roughly flat reaction. The quarter included a major regulatory milestone and commercial progress, while the call did not provide enough financial detail here to assess operating performance.

Key takeaways
  • The NRC issued a construction permit for Dow’s Long Mott project more than a month ahead of schedule; X-Energy led the reactor licensing work for Dow’s subsidiary.
  • X-Energy said the permit could serve as a proof point for other customers and help it reuse technical work across projects.
  • The company described a joint development agreement involving AEP and Amazon, but the provided transcript excerpt gives no details on its scope or economics.
  • Management cited $1.8 billion in cash and investments and up to $2.15 billion in expected federal funding support through the Department of Energy’s Advanced Reactor Demonstration Program.
Q2 2026 Aug 15, 2026

X-Energy's shares gained 3.1% following the Q2 earnings release, driven primarily by meaningful progress in securing long-term supply contracts and additional government funding that de-risk the fuel supply chain, reassuring investors on near-term project execution.

Key takeaways
  • The Department of Energy approved up to an additional $1 billion for the ARDP program, bringing total federal funding to approximately $2.1 billion under a 50-50 cost-sharing arrangement.
  • Long-term HALEU enrichment contracts with Centrus Energy and General Matter were signed, covering initial and replacement fuel needs and reducing a critical supply bottleneck.
  • An $8 million investment agreement with SGL Carbon aims to double graphite production capacity by 2030, enabling manufacturing for up to eight reactors per year.
  • Early supply chain investments are being structured to be transferred to customers, aiming to secure capacity and mitigate schedule risks for first commercial deployments.
  • Despite positive progress on supply and funding, commercial deployment remains years away, underscoring ongoing execution risks inherent at this stage.